Update on pulmonary arterial hypertension pharmacotherapy.

@article{Velayati2016UpdateOP,
  title={Update on pulmonary arterial hypertension pharmacotherapy.},
  author={Arash Velayati and Marcos G Valerio and Michael J Shen and Sohaib Tariq and Gregg M Lanier and Wilbert S Aronow},
  journal={Postgraduate medicine},
  year={2016},
  volume={128 5},
  pages={460-73}
}
Pulmonary artery hypertension (PAH) refers to several subgroups of disease in which the mean pulmonary artery pressure (mPAP) is elevated to more than 25 mm Hg, pulmonary artery wedge pressure (PAWP) ≤ 15 mmHg, and an elevated pulmonary vascular resistance (PVR) > 3 Wood units as confirmed by right heart catheterization. The prevalence and geographic… CONTINUE READING